The presence of zinc fingers in KLF14 promotes S-phase arrest in cervical cancer cells, and we postulate that this aspect will generate a basis for targeted therapy in cervical cancer and a theoretical platform for the development of cervical cancer biopharmaceuticals. The gene discussed is KLF14; the disease is cervical cancer.